Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Orthocell Flags Strong U.S. Remplir Momentum As AGM Addresses Share Growth

OCC: $0.575 +3.60% · MC: $155M

At its AGM, Orthocell said October was its strongest month of U.S. Remplir sales since launch, with early November also showing encouraging momentum; the chair said sustaining the pace over the next six months could deliver a healthy top line at significant margins. The company reported FY2026 revenue growth of 45% and cash of approximately $39 million, while noting shareholder disappointment with recent share-price performance.

Source announcements: 2026-11-06 09:35 to 2026-11-06 16:19 Sydney time
Story updated 2026-11-06 16:23 Sydney time
SourcesAGM Addresses by Chair and Managing DirectorAmended Constitution
Comments